Aurora Sheboygan Pricing: Sacituzumab Govitecan-Hziy 180 mg Intravenous Solution at $261.58

Overview: Sacituzumab Govitecan-Hziy is an advanced, targeted cancer therapy frequently used for certain breast cancers and other solid tumors, especially when prior treatments have not been effective. At Aurora Medical Center Sheboygan County, the price for a 180 mg intravenous dose is $261.58. This fee typically covers the medication itself and not the costs of administration, facility charges, or additional supportive medications. Patients should request an itemized estimate for the full scope of costs, including potential infusion fees, monitoring, and any related lab work, to avoid unexpected charges.

Cost Breakdown

• Medication (Sacituzumab Govitecan-Hziy, 180 mg): $261.58 per dose
• Administration fees: Not included in the above price; may vary based on infusion center or hospital billing
• Facility fees: Additional charges may apply for use of infusion suites or hospital outpatient departments
• Supportive care medications: Pre-medications for side-effect prevention or management may incur extra costs
• Laboratory tests and monitoring: Blood work or imaging may be required before or during treatment

Associated Costs

• Infusion supplies (IV equipment, nursing time)
• Consultation fees (oncologist or pharmacist)
• Follow-up visits and management of side effects

Insurance & Payment Advice

• Check with your insurance provider to confirm coverage for Sacituzumab Govitecan-Hziy and related services.
• Ask about prior authorization requirements—many cancer drugs require insurer approval before treatment begins.
• Inquire about copay assistance programs or manufacturer support if you are uninsured or underinsured.
• Request a comprehensive, itemized estimate from the medical center before starting treatment.

Side-Effect Considerations

• Common side effects include nausea, fatigue, decreased blood counts, and diarrhea.
• Some patients may require additional medications to manage or prevent side effects, adding to overall costs.
• Notify your healthcare team promptly if you experience severe or unexpected reactions.

Recovery Tips

• Stay hydrated and maintain a balanced diet to help manage fatigue and digestive side effects.
• Arrange for transportation and support on infusion days, as you may feel tired after treatment.
• Monitor for signs of infection or unusual symptoms and report them to your provider immediately.

Frequently Asked Questions

What is Sacituzumab Govitecan-Hziy used for?

This medication is primarily used to treat certain types of breast cancer and other solid tumors, notably in patients who have not responded to other treatments.

How is Sacituzumab Govitecan-Hziy administered?

It is given as an intravenous (IV) infusion, meaning it is delivered directly into your bloodstream through a vein.

Does the $261.58 fee cover all treatment costs?

No, this fee covers only the medication itself. Additional costs may include infusion services, facility fees, lab tests, and supportive care medications.

Will my insurance cover Sacituzumab Govitecan-Hziy?

Coverage varies by plan. You should verify with your insurer and ask about prior authorization requirements before beginning treatment.

Are there financial assistance options available?

Yes, many pharmaceutical companies and non-profit organizations offer copay assistance or patient support programs. Speak with your care team for more information.

How often will I need to receive this medication?

The dosing schedule is determined by your oncologist based on your diagnosis and treatment plan. Typically, it is given on a weekly or biweekly basis.

What are the most common side effects?

Common side effects include nausea, fatigue, low blood counts, and diarrhea. Your care team will monitor and help manage these effects.

Can I receive this treatment as an outpatient?

Yes, most patients receive Sacituzumab Govitecan-Hziy as an outpatient infusion, but this may depend on your overall health and provider recommendations.

Do I need to prepare for each infusion?

Follow your provider’s instructions, which may include fasting or taking pre-medications. Arrange for transportation if you expect to feel fatigued.

What should I do if I miss a scheduled infusion?

Contact your care team as soon as possible to reschedule and discuss any health concerns.

Are follow-up visits required after treatment?

Yes, regular follow-up visits are necessary to monitor your response to treatment and manage side effects or complications.

Aurora Medical Center Sheboygan County offers a range of medical services, including the administration of Sacituzumab Govitecan-Hziy, a medication used primarily in the treatment of certain types of cancer. This drug is provided as a 180 mg intravenous solution and is priced at $261.58 per dose, according to Aurora Sheboygan’s pricing information. Sacituzumab Govitecan-Hziy is an antibody-drug conjugate that targets cancer cells, delivering a potent chemotherapy agent directly to the tumor, which can help to minimize damage to healthy cells and improve treatment outcomes.

What is Sacituzumab Govitecan-Hziy? – Sacituzumab Govitecan-Hziy is a targeted cancer therapy used to treat certain types of breast cancer and other solid tumors by delivering chemotherapy directly to cancer cells.

How is Sacituzumab Govitecan-Hziy administered? – It is administered as an intravenous solution, meaning it is delivered directly into the bloodstream through an IV.

What is the cost of Sacituzumab Govitecan-Hziy at Aurora Medical Center Sheboygan County? – The cost for a 180 mg dose of Sacituzumab Govitecan-Hziy is $261.58.

Who might be prescribed Sacituzumab Govitecan-Hziy? – This medication is typically prescribed to patients with specific types of cancer, particularly those who have not responded to other treatments.

Are there any side effects associated with Sacituzumab Govitecan-Hziy? – Like many cancer treatments, it can have side effects, which may include nausea, fatigue, and low blood cell counts, among others.

How does Sacituzumab Govitecan-Hziy work? – It works by attaching to a protein found on cancer cells and delivering a chemotherapy agent directly to them, which helps to kill the cancer cells while sparing healthy tissue.

Is Sacituzumab Govitecan-Hziy covered by insurance? – Coverage can vary depending on the insurance provider and the patient’s specific plan, so it’s important to check with the insurance company for details.

Can Sacituzumab Govitecan-Hziy be used in combination with other treatments? – It may be used alongside other treatments, but this depends on the patient’s specific medical condition and should be determined by a healthcare provider.